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 16 
Abstract 17 
Background/Aims: A-factor, a γ-butyrolactone autoregulator, in Streptomyces griseus is 18 
involved in the regulation of differentiation and antibiotic production. Here we studied the 19 
Streptomyces griseus B2682-AFN (A-factor negative) bald mutant that harbors a nonsense 20 
mutation in the afsR gene encoding a pleiotropic regulator. Our aim was to prove that this 21 
mutation is the cause of the A-factor deficiency in AFN. We also studied if AfsR regulates A-22 
factor production by AfsA, which is supposed to be the only specific key enzyme in A-factor 23 
biosynthesis. 24 
Methods: Wild afsR was cloned to the pHJL401 shuttle vector and was transformed to the S. 25 
griseus AFN and B2682 strains.  During phenotypic characterization sporulation, antibiotic, 26 
protease, A-factor and AfsA protein production were studied.  27 
Results: Transformation of AFN by a wild afsR restored its phenotype including sporulation, 28 
antibiotic, extracellular protease and A-factor production. Introduction of afsR to the B2682 29 
wild type strain resulted in antibiotic and extracellular protease overproduction that was 30 
accompanied with elevated A-factor level.  AfsA was detected both in AFN and B2682.  31 
Conclusions: AfsR has an effect on the regulation of A-factor production in S. griseus. The 32 
presence of AfsA is not sufficient for normal A-factor production. AfsR regulates A-factor 33 
biosynthesis independently of AfsA.  34 
35 
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Introduction 36 
Streptomyces comprises Gram-positive, soil dwelling bacteria that show complex 37 
morphological differentiation terminated in sporulation [Flärdh and Buttner, 2009]. On solid 38 
medium the formation of substrate hyphae from a germinating spore is followed by the 39 
emergence of aerial hyphae, which segments into chains of spores [Flärdh and Buttner, 2009]. 40 
They are also able to produce a wide variety of secondary metabolites that makes 41 
streptomycetes one of the most important industrial microbial genus since many of the known 42 
antibiotics derive from their cultures [Chaudhary et al., 2013; Horinouchi, 2007]. The 43 
production of immunosuppressants, enzyme inhibitors, and industrial enzymes also 44 
contributes to their biotechnological significance [Chaudhary et al., 2013]. The spread of 45 
multidrug resistant bacterial pathogens represents great concern for future medicine and 46 
encourages the search for new antibiotics. According to genome mining studies 47 
streptomycetes are still promising candidates for antibiotic research [Chaudhary et al., 2013; 48 
Zhu et al., 2014]. Understanding the temporal and conditional cues that activate antibiotic 49 
production in streptomycetes would facilitate the improvement of screening efforts 50 
[Chaudhary et al,. 2013; Zhu et al., 2014]. 51 
Morphological development and secondary metabolism are simultaneously affected by 52 
various nutritional environments and controlled by extracellular signaling molecules such as 53 
γ-butyrolactones [Horinouchi, 2007].  In S. griseus A-factor (2-isocapryloyl-3R-54 
hydroxymethyl-γ-butyrolactone) is produced in a growth-dependent manner and diffuses 55 
freely across the cell membrane. When its extracellular concentration reaches a critical level it 56 
binds to the A-factor receptor protein (ArpA) leading to the transcription and translation of 57 
adpA [Horinouchi, 2002]. AdpA then activates a variety of genes that are required for 58 
secondary metabolism, morphological development and extracellular protease production 59 
forming an AdpA regulon [Ohnishi et al., 2005]. The biosynthesis of A-factor is a multistep 60 
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pathway, in which the role of AfsA proved to be essential by catalyzing a ß-ketoacyl transfer 61 
from the 8-methyl-3-oxononanoyl-acyl carrier protein to the hydroxyl group of 62 
dihydroxyacetone phosphate, thus producing an 8-methyl-3-oxononanoyl-dihydroxyacetone 63 
phosphate ester [Kato et al., 2007]. The key role of AfsA in A-factor biosynthesis is supported 64 
by the observations that i) mutants having afsA deficiency are not able to produce A-factor, ii) 65 
introduction of afsA to A-factor nonproducing strains resulted in overproduction of A-factor, 66 
iii) introduction of afsA alone to E. coli caused the host to produce a substance having A-67 
factor activity [Ando et al., 1997; Hara et al., 1983; Horinouchi et al., 1984; Kato et al., 2007].  68 
Secondary metabolism is also under the regulation of pleitropic regulators in streptomycetes, 69 
e.g. by AfsR. In S. coelicolor AfsR is activated by phosphorylation in response to unknown 70 
environmental stimuli and acts by inducing the transcription of afsS [Lee et al., 2002]. AfsS 71 
then is proved to be important in the induction of secondary metabolite production and also 72 
modulates nutritional stress response in S. coelicolor [Lee et al., 2002; Lian et al., 2008]. 73 
AfsR and/or AfsS-like regulators proved to be important in the regulation of secondary 74 
metabolite production in other streptomycetes as well including S. lividans [Kim et al., 2001], 75 
S. clavuligerus [Parajuli et al., 2005], S. venezuelae [Maharjan et al., 2009], S. 76 
pristinaespiralis [Jin et al., 2012], S. avermitilis [Lee et al., 2000], S.peucetius [Parajuli et al., 77 
2005] and S. scabies [Seipke et al., 2011]. But only a little, controversial information is 78 
available about AfsR in S. griseus. Earlier studies suggest that AfsR may be conditionally 79 
involved in the regulation of morphological differentiation but not directly needed for 80 
secondary metabolite production [Umeyama et al., 1999]. No information is available about 81 
AfsS in S. griseus. 82 
In this work we studied the S. griseus B2682-AFN strain that is not able to produce sufficient 83 
amount of A-factor to support its differentiation [Birkó et al., 2007]. The A-factor deficiency 84 
of this strain is accompanied with the block of differentiation and secondary metabolite 85 
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production that is restored by the addition of A-factor [Birkó et al., 2007]. Previous studies 86 
showed that afsA is functional and transcribed in AFN [Birkó et al., 2007]. However, a 87 
nonsense mutation was detected in the afsR gene [Zhang, 2015] that might be the cause of the 88 
A-factor deficiency of this strain. To prove this hypothesis we transformed AFN with a 89 
functional afsR. The transformation restored its phenotype that confirms the role of AfsR in 90 
the regulation of sporulation, antibiotic, protease and A-factor production in S. griseus. We 91 
also present that this regulation is independent of the A-factor biosynthetic AfsA enzyme. 92 
Results 93 
Transformation of AFN by afsR 94 
The A-factor deficient S. griseus AFN strain is a spontaneous bald mutant of the S. griseus 95 
B2682 wild type strain [Birkó et al., 2007]. To shed light on the genetic cause of the non-96 
differentiating phenotype of AFN its genome was sequenced and a nonsense mutation was 97 
identified in the afsR (SGR3012) gene [Zhang, 2015]. In S.griseus the afsR gene encodes an 98 
974 amino acid protein [Ohnishi et al., 2008]. Its promoter region contains the consensus 99 
sequence of sigma70 (-10 region: AGGCAGACT, -35region: CTGACG, predicted by the 100 
BPROM program) [Solovyev and Salamov 2011]. This suggests its expression during the 101 
growth phase that was confirmed by Umeyama et al. [1999]. In AFN a G → A transition 102 
occurred in the 2642. position that resulted in the change of Trp codon to Stop codon [Zhang, 103 
2015]. This causes the production of a 94 amino acid shorter protein product that could lead to 104 
the non-differentiating phenotype of AFN. In order to confirm this hypothesis we transformed 105 
the AFN strain with a functional copy of afsR. 106 
A 3.1 kb DNA fragment containing the afsR gene and its promoter sequence was cloned to the 107 
pHJL401 low copy number shuttle vector resulting in pHJL401-afsR.This construct was 108 
transformed to AFN that led to the S. griseus AFNpHR strain. In order to study the effect of 109 
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extra afsR copy to the phenotype of a wild type strain the pHJL401-afsR construct was also 110 
introduced to B2682 resulting in S. griseus B2682pHR. The pHJL401 empty construct was 111 
also transformed to AFN and B2682 that led to the S. griseus AFNpH and S. griseus 112 
B2682pH strains that were used as controls in the phenotypic studies.  113 
Phenotypic characterization of the S. griseus B2682, AFN, B2682pHR and AFNpHR strains 114 
In the phenotypic studies the intensity of growth, production of spores, antibiotics, and 115 
extracellular protease were investigated on rich (R5) and on minimal medium (MM). A-factor 116 
production was also detected. 117 
In liquid R5 intensive growth was observed and the strains reached stacionary phase 118 
approximately 20 hours after inoculation (Fig 1/A). No significant difference was observed in 119 
the growth intensity of the strains and the specific growth rates were also comparable (0.99 ± 120 
0.001). When growth was tested in liquid MM the strains were precultured in R5 before 121 
transfer to MM. This culturing condition is also suitable for the induction of differentiation in 122 
the liquid cultures of S. griseus [Daza et al., 1989; Birkó et al., 2007]. Nutritional shift-down 123 
decreased the length of exponential growth phase and all the strains entered stationary phase 124 
approximately 4 hours after shift (Fig 1/B). No significant difference was observed in the 125 
growth rates in MM either between the strains (0.98 ± 0.002). 126 
Aeral mycelium and spore production were studied on solid R5 and MM medium. S. griseus 127 
B2682 strain produced aerial mycelium on both of the media but in case of the AFN strain it 128 
was medium dependent. No aerial hyphae could be discerned with the naked eye on rich R5 129 
medium but spores could be seen by light microscopy inside the colonies (Fig 2/A). These 130 
spores were formed likely from the substrate mycelium and their shape and size were less 131 
regular than those formed from the aerial mycelium in case of the B2682 strain (Fig 2/A). 132 
Aerial mycelium formation and sporulation were detected in AFN growing on MM although 133 
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the amount of spores was reduced compared to the B2682 strain (Fig 2/B). Aerial hyphae 134 
formation was restored in the AFNpHR strain on R5 (Fig 2/A). Transformation of B2682 135 
strain with pHJL401-afsR did not alter its sporulation (Fig 2/A and 2/B).  136 
Antibiotic production was detected by a growth inhibition assay, as follows. The strains were 137 
grown for 7 days on R5 or MM then antibiotic testing medium mixed with B. subtilis spores 138 
was overlaid on the S. griseus colonies. Clear zones – with 39 ± 1 mm on R5 and 30 ± 1 mm 139 
on MM in diameter - indicating antibiotic production could be seen around the colonies of the 140 
B2682 strain (Fig 2/A and 2/B). But no antibiotic production was detected in the case of the 141 
AFN strain neither on R5 or MM (Fig 2/A and 2/B). Transformation of AFN with afsR 142 
restored its antibiotic production on both R5 and MM (Fig 2/A and 2/B). Moreover, it resulted 143 
in antibiotic overproduction especially on R5medium (Fig 2/A; 52 ± 2 mm inhibitory zone 144 
diameter) compared to the B2682 strain. The B2682pHR strain was also capable of antibiotic 145 
overproduction on R5 (Fig 2/A; 47 ± 2 mm inhibitory zone diameter). All the strains 146 
produced less antibiotics on MM than on R5 medium (Fig 2/A and 2/B).  147 
Extracellular protease production was studied in liquid cultures. Extracellular protease activity 148 
increased continuously in the cultures of the B2682 strain on both R5 and MM (Table 1). In 149 
the case of the AFN strain only negligible extracellular protease production was observed 150 
(Table 1). Transformation of the AFN strain with pHJL401-afsR markedly increased its 151 
extracellular protease production compared to the AFN strain and this activity proved to be 152 
higher than the protease activity measured in the B2682 strain in both R5 and MM (Table 1). 153 
The extracellular protease formation of the B2682pHR strain was also elevated compared to 154 
the B2682 strain (Table 1). We observed that all the strains produced more extracellular 155 
protease enzymes in MM than in R5 (Table 1).  156 
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It is generally accepted that A-factor is produced during the growth phase [Horinouchi, 2002]. 157 
Since much more intensive growth was observed in liquid R5 than in MM A-factor 158 
production was studied in rich medium only. A-factor production of the strains was 159 
determined by Mass Spectrometry. The B2682 wild type strain produced 27.3 ng ml
-1
 A-160 
factor (Table 2) that is in good agreement with the previous observation that A-factor reaches 161 
25 to 30 ng ml
-1
 concentration in late exponential cultures [Horinouchi ,2002]. The AFN 162 
strain produced lower amount of A-factor than the B2682 strain as expected (Table 2). In the 163 
AFNpHR strain elevated A-factor production was observed that was comparable with the A-164 
factor level produced by the B2682 strain (Table 2). It is also important to mention that 165 
introduction of afsR to B2682 resulted in increased A-factor production compared to the 166 
B2682 strain (Table 2). 167 
Transformation of the empty pHJL401 plasmid to the AFN or B2682 strains did not influence 168 
their sporulation, antibiotic, extracellular protease or A-factor production (data not shown). 169 
Detection of AfsA protein production in S. griseus AFN and B2682 strains 170 
In our further studies we investigated whether AfsR affects A-factor biosynthesis by 171 
regulating AfsA that is considered to be the only specific key enzyme in A-factor biosynthesis 172 
[Ando et al., 1997]. The afsA gene encodes a 314 amino acid protein [Ohnishi et al., 2008]. 173 
The promoter region of afsA contains the consensus sequence for sigma70 (-10 region: 174 
CTGCAAGAT, -35region: TTCCCG [Solovyev and Salamov 2011] that suggests its 175 
expression during the growth phase. It is in good accordance with the fact that A-factor is 176 
produced during growth [Horinouchi, 2002].  177 
In order to study the presence of AfsA protein an anti-AfsA antibody was required. For this 178 
purpose we produced the AfsA protein as an AfsA-GST fusion protein in E. coli 179 
(Supplementary text; Supplementary Figure). The purified AfsA-GST and AfsA proteins were 180 
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used for the immunization of rabbits. The AfsA protein was identified by Western blotting. 181 
To ascertain translation of afsA in the S. griseus AFN and B2682 strains submerged cultures 182 
were studied according to previous transcription studies [Birkó et al., 2007]. The same 183 
culturing conditions were used as described earlier: strains were pregrown in R5 and 184 
transferred to MM. Samples were taken before (0 h sample, cultured in R5) and 2 hs after the 185 
transfer (2 h sample, cultured in MM). This condition made AfsA detection possible during 186 
intensive growth – when A-factor is produced – and after the induction of differentiation by 187 
nutritional shift-down. AfsA protein was detectable in both of the conditions (Fig 3). The 188 
presence of AfsA was detected not only in the B2682 but also in the AFN strain at both of the 189 
media (Fig 3). Although this is not a quantitative measurement our result suggests that AfsA 190 
production is decreased after the induction of differentiation in B2682 that did not occur in the 191 
AFN mutant (Fig 3). Similar results were obtained for the synthesis of afsA mRNA [Birkó et 192 
al., 2007]. 193 
Discussion 194 
The γ-butyrolactone molecules serve as key factors in the control of secondary metabolism in 195 
streptomycetes. However, little is known about the regulation of their synthesis. Shedding 196 
light on the regulatory processes in details has a great significance in the development of 197 
antibiotic overproducing strains since these molecules can enhance the production of 198 
antibiotics at very low concentration. Elevated γ-butyrolactone production may also support 199 
the induction of cryptic antibiotic gene clusters and industrially relevant extracellular 200 
proteases. Our results raise the possible role of AfsR in the regulation of morphological and 201 
physiological differentiation by influencing A-factor biosynthesis in S. griseus. 202 
Here we studied the A-factor deficient S. griseus B2682-AFN strain that harbors a nonsense 203 
mutation in the afsR gene [Birkó et al., 2007; Zhang, 2016]. The non-differentiating 204 
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phenotype of AFN could be restored by exogenously added A-factor or by introducing the 205 
facC gene to AFN - that is responsible for the synthesis of factor C, which is an 206 
autoregulatory protein essential for the induction of differentiation in S. albidoflavus 207 
(formerly known as S. griseus 45H) [Birkó et al., 2007; 2009; Kiss et al., 2008]. These 208 
observations suggest that all the genes that function in the mode of action or in the 209 
biosynthesis of A-factor – including AfsA - are functional in AFN [Birkó et al., 2007; 2009]. 210 
The fact that AFN harbors a mutation in the afsR gene suggests that this mutation might be 211 
responsible for the bald phenotype of AFN and raises the possible role of AfsR in the 212 
regulation of A-factor biosynthesis. To prove this hypothesis we introduced a wild afsR copy 213 
to the AFN strain. Due to the transformation the phenotype of AFN was restored including 214 
sporulation, extracellular protease and antibiotic production. Moreover the A-factor 215 
production of this transformant was also comparable with the A-factor level of the B2682 216 
wild type strain. Increasing the copy number of afsR in B2682 resulted in elevated A-factor, 217 
extracellular protease and antibiotic production. Elevated production of secondary metabolites 218 
by the enhanced expression of AfsS and/or AfsR-like regulators was also experienced in other 219 
streptomycetes including S. coelicolor [Floriano and Bibb, 1996; Matsumoto et al., 1995], S. 220 
lividans [Vogtli et al., 1994], S. avermitilis [Lee et al., 2000], S. noursei [Sekurova et al., 221 
1999], S. peucetius [Parajuli et al., 2005] and S. venezuelae [Maharjan et al., 2009].  It is also 222 
important to mention that introduction of afsR from S. peucetius – sharing 61% sequence 223 
identity with afsR of S. griseus - to S. griseus also resulted in streptomycin overproduction 224 
[Parajuli et al., 2005]. However, to the best of our knowledge the effect of AfsR to γ-225 
butyrolactone biosynthesis has not been studied yet. According to our results – both the 226 
mutation in afsR or increasing its copy number influenced A-factor production – AfsR might 227 
have a role in the regulation of A-factor biosynthesis in S. griseus. 228 
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Our results show that medium composition has a great influence on differentiation. Nutrient 229 
limitation is able to induce aerial mycelium and spore formation even in an A-factor deficient 230 
strain. However, A-factor seems to be essential in the induction of antibiotics and 231 
extracellular protease production regardless of medium composition. Rich medium supports 232 
the production of more antibiotics that is in good agreement with the fact that secondary 233 
metabolites require nitrogen compound precursors [Romero-Rodríguez et al., 2018]. On the 234 
contrary, elevated extracellular protease production was observed during nutrient limitation. 235 
This observation confirms that these enzymes are responsible for the degradation of substrate 236 
mycelium in order to provide nutrients and energy for spore formation [Kato et al., 2002; Kim 237 
et al., 2008]. 238 
We also studied if AfsR affects the biosynthesis of A-factor by influencing the A-factor 239 
biosynthetic AfsA enzyme that is supposed to be the only specific key enzyme of A-factor 240 
biosynthesis [Ando et al., 1997]. In this case the decreased level of A-factor would have been 241 
accompanied with the decreased amount/absence of AfsA protein in the AFN strain. 242 
However, Western blot results confirmed the presence of AfsA protein in the AFN strain that 243 
was comparable to the level observed in the B2682 strain in R5.  Our results suggest that 244 
during intensive growth the i) the role of AfsR is independent of AfsA in the regulation of A-245 
factor biosynthesis, ii) the presence of AfsA alone is not enough for the sufficient production 246 
of A-factor, iii) there is no correlation between the A-factor and AfsA level in S. griseus. We 247 
hypothesize that A-factor biosynthesis during growth is controlled by other mechanisms, e.g. 248 
by the availability of substrates for A-factor biosynthesis as it was also suggested earlier 249 
[Horinouchi, 2007]. The concentration of dihydroxyacetone phosphate (derives from 250 
glycolysis) and 8-methyl-3-oxononanoyl-acyl carrier protein (derives from the condensation 251 
of isobutyryl-CoA and acetate units leaked from the fatty acid biosynthesis) highly depends 252 
on the physiological state of the cell. We suggest that AfsR might affect the metabolic flux 253 
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that fuels A-factor biosynthesis in the cell. It is also important that afsA expression was 254 
decreased after the induction of differentiation by nutritional shift-down in the B2682 strain 255 
that did not occur in AFN. This is in good agreement with the observation that A-factor 256 
production is repressed after the induction of differentiation that might be mediated by AdpA 257 
in a two-step regulatory feedback loop [Kato et al., 2004].  Our future aim is to shed light on 258 
this regulation in details that could lead to the better understanding of the regulation of A-259 
factor biosynthesis.  260 
Experimental procedures 261 
Streptomyces strains and culture conditions 262 
The strains used in this study were S. griseus NRRL B2682 (wild type parental strain, in short 263 
B2682) and its spontaneous A-factor negative bald mutant S. griseus NRRL B2682-AFN (in 264 
short AFN) [Birkó et al., 2007; 2009]. The following strains were created in this study: S. 265 
griseus NRRL B2682 pHJL401 (in short B2682pH), S. griseus NRRL B2682 pHJL401-afsR 266 
(in short B2682pHR), S. griseus NRRL B2682-AFN pHJL401 (in short AFNpH), S. griseus 267 
B2682-AFN pHJL401-afsR (in short AFNpHR). All the strains were maintained on solid R5 268 
medium [Kieser et al., 2000] at 30 °C for 7 days. In the case of the S. griseus AFNpH, 269 
AFNpHR, B2682pH and B2682pHR strains the medium was supplemented with 25 μg ml-1 270 
thiostrepton. 271 
To investigate areal mycelium and spore formation Streptomyces strains were cultivated on 272 
solid R5 or MM at 30 °C for 7 days. To assay growth kinetics, the production of AfsA protein 273 
and extracellular proteases submerged cultures were used. In these experiments two different 274 
culturing conditions were used. During the phenotypic studies in R5 Streptomyces strains 275 
were cultivated in 50 ml R5 medium for 96 h (30 °C; 250 rpm) and samples were taken  48, 276 
72 and 96 hours after inoculation (for extracellular protease production). When the strains 277 
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were tested on MM, the strains were precultured in R5 medium until A550 = 0.7. Then mycelia 278 
were separated and transferred into 50 ml minimal medium (MM) [Kieser et al., 2000] and 279 
further cultivated for 72 h. Samples were taken at the time of shift (0 h) and 2 (for Western 280 
Blot) or 24, 48 and 72 hours (for extracellular protease detection) after transfer. Growth 281 
intensity was studied in the liquid cultures photometrically (A550). Note that samples with 282 
absorbance higher than 1 were diluted with the appropriate medium before measurement. In 283 
the case of the S. griseus AFNpH, AFNpHR, B2682pH and B2682pHR strains the medium 284 
was supplemented with 2.5 μg ml-1 thiostrepton. 285 
Transformation of Streptomyces strains 286 
The pHJL401 plasmid (low copy number, ̴ 10 copies/cell [Kieser et al., 2000]), and its 287 
derivative -pHJL401-afsR- were used for transformation. The pHJL401-afsR plasmid was 288 
constructed as follows. The afsR sequence and the 192 bp upstream sequence containing the 289 
promoter region of afsR was amplified by PCR with B2682 genomic DNA as a template using 290 
the following primers: afsR-F 5’-GCGTCTAGACTTGTGCAGAGCGTCACCCACT-3’ (with 291 
an XbaI site shown by italics) and afsR-R 5’-292 
GCCGAATTCAACGATTGATGAACGCCTCCGC-3’ (with an EcoRI site shown by italics). 293 
Promoter position was predicted by the BPROM program [Solovyev and Salamov 2011]. 294 
PCR fragment was cloned to the pHJL401 plasmid between the XbaI and EcoRI sites. The 295 
pHJL401-afsR plasmid purified from the E. coli ET12567 methylation deficient strain was 296 
used for transformation [MacNeil et al., 1992].  297 
During the transformation of S. griseus B2682 and AFN strains the PEG-assisted 298 
transformation of Streptomyces protoplasts method was used [Kieser et al., 2000]. S. griseus 299 
strains were cultivated in liquid GYM medium. Protoplasts were prepared by incubating the 300 
culture in lysozyme solution (1 mg ml
-1
) as described elsewhere [Kieser et al., 2000]. The 301 
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number of the protoplasts was determined using a haemocytometer. During transformation 5 302 
µg plasmid DNA (pHJL401 or pHJL401-afsR) was added to 4 x 109 protoplasts in the 303 
presence of P-buffer that was supplemented with 25 % PEG [Kieser et al., 2000]. For 304 
regeneration protoplasts were spread on the surface of R5 agar plates and were incubated at 305 
30 °C for 24 h. Selection of transformants was carried out by flooding 1.5 ml thiostrepton 306 
containing solution (0.66 mg ml
-1
) on the surface of the agar plates [Kieser et al., 2000]. 307 
Negative controls were used in every transformation experiment in order to check 308 
transformation efficiency. 309 
Detection of antibiotic production 310 
Antibiotic production of S. griseus colonies were assayed on surface grown cultures. 311 
Streptomyces strains were grown on solid R5 for 7 days at 30 °C. Antibiotic medium (5 g l-1 312 
meat extract, 1 g l
-1 
Na2HPO4, 0.1 g l
-1 
KH2PO4, 0.5 g l
-1 
Bacto peptone) mixed with Bacillus 313 
subtilis ATCC 6633 spores was overlaid on the Streptomyces colonies. The plates were 314 
further incubated at 37 °C for 18 h and the formation of growth inhibition zone around the 315 
Streptomyces colonies was detected [Horinouchi et al., 1984].  316 
Determination of protease activity 317 
0.1 ml fermentation broth samples were incubated (60 min, 37 °C) in 0.2 mol l-1 Na2HPO4/0.1 318 
mol l 
-1
 citric acid buffer (pH 8) with azocasein substrate (12.5 mg ml
-1
 final concentration) as 319 
described elsewhere [Szilágyi et al., 2011]. One unite (U) of protease activity was defined as 320 
an amount of enzyme resulting in 1 OD increase in the absorbance at 440 nm. Protease 321 
activities are presented in U ml
-1
. 322 
Detection of A-factor production 323 
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A-factor was extracted from liquid grown cultures after 48 h of growth with equal amount of 324 
chloroform as described earlier [Birkó et al., 2007]. A-factor concentrations are presented in 325 
ng ml
-1
 culture. A-factor concentration of the extracts was determined by Mass Spectrometry 326 
(MS). These measurements were obtained on a Waters QTOF Premiermass  spectrometer 327 
(Milford, USA) equipped with an electrospray (ESI) source. The instrument was operated in 328 
negative ion mode using enhanced sensitivity scan focused to 241 m/z and fragment ion scan 329 
mode (MSMS) of 241 m/z. Fragment ion scans and the retention time data was used to 330 
confirm the presence of the molecule in the sample. The quantitative determination of A-331 
factor based on the mass chromatogram of the 241 ion. Ion intensities were compared to the 332 
intensities of the standard solution. Matrix effect was excluded using standard spiked 333 
biological samples. Samples were subjected to gradient HPLC separation before MS analysis. 334 
(Mobile phases were A: water and formic 99.95/0.05 v/v, B: acetonitrile, formic acid 100:0.05 335 
v/v HPLC apparatus: Applied Biosystems 140C; flow rate: 250 µl min-1; gradient: 40-100 15 336 
min; column: Kinetex 5u EVO C18 100A C18, 150x2.1 mm). 337 
Antibodies 338 
The primary antibody used to detect the presence of AfsA protein in this study was rabbit 339 
polyclonal antibody. AfsA protein was produced as AfsA-GST fusion protein by E. coli BL21 340 
cells harboring the pGEX-4T1-afsA plasmid (Supplementary text; Supplementary Figure). 341 
Purified AfsA-GST and AfsA proteins were used for the immunization of New Zealand white 342 
rabbits. The antibodies were purified on protein A column. Rabbit immunization and antibody 343 
purification were performed by Covalab (www.covalab.com). The secondary antibody in 344 
Western Blot studies was horseradish peroxidase-coupled anti-rabbit antibody (Covalab). 345 
SDS-PAGE and Western Blotting 346 
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Mycelia of S. griseus AFN and B2682 strains derived from submerged cultures were 347 
centrifuged, washed and resuspended in PBS. Cells were disrupted by sonication. Proteins 348 
were separated by electrophoresis in a 12% polyacrylamide gel. Western blot was prepared 349 
using a Trans Blot Semi Dry Transfer Cell (Bio-Rad) and PVDF membrane in Towbin buffer 350 
according to the manufacturer’s instructions. After transfer the membrane was incubated in 351 
blocking buffer (50 g l
-1
 non fat milk powder in PBS) for 1 h, and washed in PBS. For 352 
immunodetection the blot was incubated with the primary polyclonal antibody (1:1000 353 
dilution, 4 °C, overnight). Before the incubation with secondary antibody (1:2000 dilution) 354 
the blot was washed in PBS. For chromogenic detection 3.3-diaminobenzidine (0.5 g l
-1
 in 355 
PBS supplemented with 0.3% H2O2) was used as substrate. 356 
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Table 1. Extracellular protease activity in the submerged cultures of Streptomyces griseus 474 
AFN, B2682, AFNpHR and B2682pHR strains. 475 
Strains   Specific protease activity U ml 
-1
  
48 h  72 h  96 h  
R5 MM R5 MM R5 MM 
AFN 0 ± 0.01 0.1 ± 0.1 0.01 ± 0.01 0.3 ± 0.1
#
 0.01 ± 0.01 0.2 ± 0.1# 
B2682 1.43 ± 0.1 1.4 ± 0.2 2.1 ± 0.2 3 ± 0.3
#
 3 ± 0.2 3.6 ± 0.3# 
AFNpHR 2.54 ± 0.2* 2.8 ± 0.3* 4 ± 0.3* 4.2 ± 0.5* 5.1 ± 0.3* 5.9 ± 0.5*
#
 
B2682pHR 1.44 ± 0.2 1.7 ± 0.2 2.2 ± 0.2 3.7 ± 0.3*
#
 3.5 ± 0.2* 4.3 ± 0.4*# 
 476 
The strains were inoculated to R5 and cultivated for 96 hours. When protease production was 477 
studied in MM the strains were pregrown in R5 than transferred to MM and cultivated further 478 
for 72 hours . Samples were taken 48, 72 and 96 hours after inoculation. All data represent 479 
mean ± SD values calculated from 4 independent experiments. * stands for significant (p < 480 
0.05) differences from the B2682 strain calculated by the Student’s t-test. # stands for 481 
significant (p < 0.05) differences between the activities detected in R5 and MM in each of the 482 
strains calculated by the Student’s t-test. 483 
484 
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Table 2. A-factor production of the cultures of Streptomyces griseus AFN, B2682, AFNpHR 485 
and B2682pHR strains. 486 
Strains A-factor concentration ng ml 
-1 
culture 
AFN 13.6 ± 1.5 
B2682 27.3 ± 2.5 
AFNpHR 25 ± 2.7* 
B2682pHR 38.8 ± 3.9** 
 487 
All data represent mean ± SD values calculated from 4 independent experiments. Symbols * 488 
or ** stand for significant differences from the AFN or B2682 strains calculated by the 489 
Student’s t-test (p < 0.01). 490 
491 
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Figure 1 492 
Growth curves of the liquid cultures of Streptomyces griseus AFN, B2682, AFNpHR and 493 
B2682pHR strains in R5 (A) and in MM (B). Strains were inoculated to R5 and cultivated for 494 
30 hours (A). When growth was tested in MM the strains were pregrown in R5 to A550=0.7 495 
and transferred to MM (B). 496 
 497 
 498 
 499 
 500 
 501 
 502 
 503 
 504 
505 
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Figure 2/A 506 
 507 
 508 
509 
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 510 
Figure 2/B 511 
 512 
Sporulation and antibiotic production of Streptomyces griseus AFN, B2682, AFNpHR and 513 
B2682pHR strains on R5 (A) and on MM (B). Streptomyces colonies were grown on solid 514 
R5. The photos and microscopic images (Bar = 10 µm) of the cultures were taken 7 days after 515 
inoculation. To detect antbiotic production agar medium mixed with Bacillus subtilis spores 516 
was overlaid on the Streptomyces colonies after 7 days of incubation. The formation of 517 
growth inhibition zone of Bacillus subtilis around the Streptomyces colonies showed the 518 
production of antibiotics. 519 
 520 
521 
27 
 
Figure 3 522 
 523 
Detection of AfsA protein in the submerged cultures of Streptomyces griseus AFN and B2682 524 
strains by Western blot. Differentiation was induced by nutritional shift-down. Samples were 525 
taken at the time of shift (0 h sample, cultured in R5) and 2 h after nutritional shift down (2 h 526 
sample, cultured in MM).  527 
 528 
529 
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Supplementary material 530 
Expression and purification of recombinant AfsA-GST 531 
To produce AfsA-GST fusion protein afsA was cloned to the pGEX-4T1 plasmid (GE 532 
Healthcare) as follows. The afsA sequence was amplified by PCR with B2682 genomic DNA 533 
as a template using the following primers: afsA-F 5’-534 
GAATTCATGCCCGAAGCAGCAGTCTTGATCG-3’ (with an EcoRI site shown by italics) 535 
and afsA-R 5’-GCGGCCGCTCAGCCGTGGGCCCGGGGGCCGGAC-3’ (with a NotI site 536 
shown by italics). The blunt-end PCR product was cloned to the pJET1.2 plasmid (Thermo 537 
Fisher Scientific). The EcoRI-NotI fragment was excised from pJET1.2-afsA and cloned 538 
between the EcoRI and NotI sites of pGEX-4T1, resulting in pGEX-4T1-afsA, which was 539 
transformed to E. coli BL21.  540 
During the production of AfsA-GST this E. coli strain was incubated in Luria Broth (LB) 541 
medium supplemented with 100 µg ml-1 ampicillin (30 °C; 250 rpm). Fusion protein 542 
expression was induced by 0.1 mM IPTG. Cells harvested by centrifugation were washed and 543 
suspended in PBS buffer. Cells were disrupted by sonication. Expression yielded low amount 544 
of fusion protein in the soluble fraction due to the formation of insoluble inclusion bodies 545 
(Supplemetaly Figure). In order to dissolve the inclusion bodies the pellet obtained from 546 
sonication was solubilized with 5M urea [Harper and Speicher, 2011]. To refold the denatured 547 
AfsA-GST urea was removed by successive dialysis [Harper and Speicher, 2011]. To purify 548 
the recombinant AfsA-GST protein Gluthatione GST-bind resin (Millipore) was used by 549 
following the manufactural instructions. GST-fusion protein bound to the resin was either 550 
eluted directly by 10 mM reduced gluthatione containing elution buffer or was cleaved on the 551 
resin by thrombin. Each of the steps were monitored by SDS-PAGE (Supplemetary Figure). 552 
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Harper S, Speicher DW: Purification of proteins fused to glutathione S-transferase. Methods 554 
Mol Biol 2011;681:259-80.  555 
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Supplementary Figure 558 
 559 
Purification of recombinant AfsA (Panel A) and its detection by antibody (Panel B). Panel A: 560 
The AfsA-GST fusion protein was purified from the culture of E. coli BL21 harboring pGEX-561 
4T1-afsA with Gluthatione GST-bind resin and was cleaved by thrombin. Symbols: A: 562 
sediment after sonication, B: supernatant after sonication, C: sediment after urea treatment, D: 563 
purified AfsA-GST fusion protein, E: AfsA and GST proteins after the cleavage of the fusion 564 
protein by thrombin, L: protein molecular weight ladder. Purified AfsA-GST and AfsA 565 
proteins were used for the immunization of rabbits. Panel B: The purified rabbit polyclonal 566 
antibodies proved to be active against the recombinant AfsA-GST and AfsA proteins by 567 
Western blot. Note that the AfsA protein (36 kDa) contains a thrombin cleavage site that 568 
results the smaller fragment (28 kDa). 569 
 570 
